Cargando…

Systemic complement activation in central serous chorioretinopathy

PURPOSE: A clear link between several variants in genes involved in the complement system and chronic central serous chorioretinopathy (CSC) has been described. In age-related macular degeneration, a disease that shows clinical features that overlap with CSC, both genetic risk factors and systemic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Elon H. C., Tsonaka, Roula, Klar-Mohamad, Ngaisah, Wouters, Diana, de Vries, Aiko P. J., de Jong, Eiko K., van Kooten, Cees, Boon, Camiel J. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495432/ https://www.ncbi.nlm.nih.gov/pubmed/28671968 http://dx.doi.org/10.1371/journal.pone.0180312

Ejemplares similares

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2023)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

Central serous chorioretinopathy in active endogenous Cushing’s syndrome
por: Brinks, Joost, et al.
Publicado: (2021)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data
por: Subhi, Yousif, et al.
Publicado: (2021)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy
por: Kumar, Meenakshi, et al.
Publicado: (2020)

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
por: Brinks, Joost, et al.
Publicado: (2022)

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence
por: Pfau, Maximilian, et al.
Publicado: (2021)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy
por: van Haalen, Femke M., et al.
Publicado: (2018)

SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Pauleikhoff, Laurenz J.B., et al.
Publicado: (2023)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Exome sequencing in patients with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019)

Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification
por: Jain, Manish, et al.
Publicado: (2022)

Response to Letter to the Editor From Behar-Cohen et al.: The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2021)

The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2021)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020)

Management of central serous chorioretinopathy: Expert panel discussion
por: Chhablani, Jay, et al.
Publicado: (2018)

Properdin and factor H production by human dendritic cells modulates their T‐cell stimulatory capacity and is regulated by IFN‐γ
por: Dixon, Karen O., et al.
Publicado: (2017)

Scientific Literature Database Coverage of Randomized Clinical Trials for Central Serous Chorioretinopathy
por: Boberg-Ans, Lars C., et al.
Publicado: (2023)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy
por: Zhang, Lyvia, et al.
Publicado: (2023)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jrubqv8al7v36kf1vi6rp7k854